Prognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALL-Reference-Cited by-同舟云学术

Prognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALL

Published:2018-07-02 Issue:1 Volume:60 Page:258-261
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ampatzidou Maria¹,Paterakis Georgios²,Vasdekis Vassilios³,Papadhimitriou Stephanos I.⁴,Papadakis Vassilios⁵,Vassilopoulos Georgios⁵,Polychronopoulou Sophia¹

Affiliation:

1. Department of Paediatric Haematology-Oncology, ‘Aghia Sophia’ Children’s Hospital, Athens, Greece;

2. Flow Cytometry Department, Laboratory of Immunology, ‘G. Gennimatas’ General Hospital, Athens, Greece;

3. Department of Statistics, University of Economics, Athens, Greece;

4. Department of Molecular Cytogenetics, Laboratory of Hematology, ‘G. Gennimatas’ General Hospital, Athens, Greece;

5. Department of Hematology, University Hospital of Larisa, Thessaly Medical School, Larisa, Greece

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1471603

Reference14 articles.

1. Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia

2. Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow

3. Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction

4. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

5. Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols;Diagnostics;2023-04-28

2. A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement;Pediatric Blood & Cancer;2023-03-28

3. Copy Number Alteration Profile Provides Additional Prognostic Value for Acute Lymphoblastic Leukemia Patients Treated on BFM Protocols;Cancers;2021-06-30

4. Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients;Neoplasma;2021

5. Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease;Oncohematology;2020-10-16